Müller, Emilia (Bavaria (govt) 200809 Minister of Economics) |
n. a. |
Bavaria (govt region) |
Germany |
Müller, Hubert (Fraunhofer PST 200407) |
n. a. |
Fraunhofer (Group) |
Germany |
Müller, Philpp (Boehringer 202111 at Boehringer Ingelheim Venture Fund) |
n. a. |
Boehringer Ingelheim (Group) |
Germany |
Müller, Steffen (Merck KGaA 200601) |
n. a. |
Merck (DE) (Group) |
Germany |
Müllershausen, Florian (Novartis 201808 at Novartis Venture Fund) |
n. a. |
Novartis (Group) |
Switzerland |
Märzendorfer, Walter (Siemens 200909 Siemens Healthcare Head Magnetic Resonance) |
n. a. |
Siemens (Group) |
Germany |
Möhler, Hanns |
n. a. |
University of Zurich (UZH) |
Switzerland |
Mölders, Monika (Roche 201308 Roche Diagnostics GmbH) |
n. a. |
Roche (Group) |
Germany |
Nacke, Raoul (Eric Salmon & Partners 201305 Head of German business) |
n. a. |
Eric Salmon & Partners (Group) |
Germany |
Nagel, Roman |
n. a. |
ING (Group) |
Germany |
Narayanan, Sabrina (Biofrontera 200801– Media-Scientific Expert before Galderma) |
n. a. |
Biofrontera (Group) |
Germany |
Nauntofte, Birgitte (Novo Group 202012 CEO of Novo Nordisk Foundation) |
n. a. |
Novo Group (Group) |
Denmark |
Navabi, Stefanie (Biometra 200710) |
n. a. |
Endress+Hauser (Group) |
Germany |
Neecke, Holger |
n. a. |
Asahi Glass (AGC) (Group) |
Italy |
Needham, Miles (FRP Advisory 201707) |
n. a. |
FRP Advisory LLP |
United Kingdom (GB) |
Neiss, Ursula |
n. a. |
Roche (Group) |
Germany |
Nelson, Michael C. (Thermo Fisher 201008 Thermo Fisher Austin) |
n. a. |
Thermo Fisher (Group) |
United States (USA) |
Neubauer, Gerd |
n. a. |
Industrie- und Handelskammer |
Germany |
Neuhaus, Eckhart (Advalytix co-founder) |
n. a. |
Danaher (Group) |
Germany |
Neumann, Birgit (Bayer Technology Systems 200503) |
n. a. |
Bayer (Group) |
Germany |
Neumann, Lars (Proteros 201305 VP Discovery Projects + Project Manager) |
n. a. |
Proteros (Group) |
Germany |
Neusser, Marcus (Bio-Rad Laboratories GmbH 200512) |
n. a. |
Bio-Rad (Group) |
Germany |
Newton, Chris (BioFocus 200808 Senior VP) |
n. a. |
Charles River (Group) |
United Kingdom (GB) |
Niebling, Anna (AntiProt GmbH 2007) |
n. a. |
AntiProt GmbH |
Germany |
Niederfeld, Thomas (Avontec 200404– joined from Carl Zeiss) |
n. a. |
Avontec GmbH |
Germany |
Niel, Xavier |
n. a. |
|
|
Niemeyer, Christof M. |
n. a. |
Technical University Dortmund (TU Dortmund) |
Germany |
Nietfeld, Wilfried |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
Niethammer, Thomas |
n. a. |
Eurofins (Group) |
Germany |
Nieuwenhuizen, Peter (ECBF 202202) |
n. a. |
ECBF (European Circular Bioeconomy Fund) (Group) |
Germany |
NN (NO NAME) |
n. a. |
|
|
Nolan, Peter (Oxford BioMedica 200507) |
n. a. |
Oxford Biomedica (Group) |
United Kingdom (GB) |
Nordhof, Eckard |
n. a. |
Bico (Group) |
Germany |
Nüsslein-Vollhard, Christiane |
n. a. |
Taconic (Group) |
Germany |
Näsström, Jacques |
n. a. |
Karolinska Investment Fund |
Sweden |
O'Kelly, Stafford (Abbott 200803 VP Molecular Diagnostics) |
n. a. |
Abbott (Group) |
United States (USA) |
Oberholz, Alfred (VCI 200808 chairman) |
n. a. |
VCI (Verband der Chemischen Industrie e. V.) |
Germany |
Oberländer, Monique (CCS Cell Culture Service 201105) |
n. a. |
Evotec (Group) |
Germany |
Oberländer, Uwe (Roche Diagnostics GmbH 200703 Leiter Marketing Labordiagnostik) |
n. a. |
Roche (Group) |
Germany |
Oldekor, Herr |
n. a. |
Deutsche Bank (Group) |
Germany |
Olek, Alexander (Epigenomics 200508) |
n. a. |
Epigenomics (Group) |
Germany |
Oliff, Allen (GSK 200612 SVP Molecular Discovery Research) |
n. a. |
GSK (Group) |
United Kingdom (GB) |
Olsen, John (Hogarth Partnership 200407) |
n. a. |
Hogarth Partnership |
United Kingdom (GB) |
Oomens, Jos (FOM Institute 200507) |
n. a. |
FOM Institute AMOLF |
Netherlands |
Oostdyk, Timothy S. (Eurofins 201606 Chairman Eurofins Lancaster Labs + Group SVP BioPharma Product Testing) |
n. a. |
|
|
Orquera, Christian |
n. a. |
Bankgesellschaft Berlin (Group) |
Germany |
Orville, Jake (NextGen 200611– VP Global Sales) |
n. a. |
NextGen (Group) |
United Kingdom (GB) |
Oster, Wolfgang |
n. a. |
PolyTechnos Funds |
Germany |
Osterwalder, Bruno (Roche + Merck Serono) |
n. a. |
Roche (Group) |
Switzerland |
Ostuni, Emanuele (ArtBio 202401 CEO + Co-Founder) |
n. a. |
ArtBio (Group) |
United States (USA) |
Otto, Bernd |
n. a. |
Fraunhofer (Group) |
Germany |
Otto, Janko |
n. a. |
Schott (Group) |
Germany |
Otto, Michael (Otto Group 201502) |
n. a. |
|
|
Ovaskainen, Jari |
n. a. |
Preon Capital (family office of Jari Ovaskainen) |
Switzerland |
Owa, Takashi (Eisai 201910 VP Chief Medicine Creation + Chief Discovery Officer) |
n. a. |
Eisai (Group) |
Japan |
O’Brien, Christine (Tizona Therapeutics 201804 VP Program Management) |
n. a. |
Tizona Therapeutics Inc. |
|
O’Connell, John (InforSense 200508– Board Director) |
n. a. |
Danaher (Group) |
United Kingdom (GB) |
O’Donovan, Kevin (Evogen Ltd 200608 Chairman before Co-Founder Hybaid Ltd) |
n. a. |
Evogen (Group) |
United Kingdom (GB) |
O’Halloran, Jonathan (QuantuMDx 201409 inventor of Q-POC device) |
n. a. |
QuantuMDx (Group) |
United Kingdom (GB) |
O’Kelly, Stafford (Abbott 200812 VP Molecular Diagnostics) |
n. a. |
Abbott (Group) |
United States (USA) |
Painter, Alex-James (Univ Cambridge 200706) |
n. a. |
University of Cambridge |
United Kingdom (GB) |
Palacios, José Ma (Almirall 200508) |
n. a. |
Almirall (Group) |
Spain (España) |
Pambianchi, Wayne (Sage Group 201409) |
n. a. |
Sage Group (Group) |
United States (USA) |
Pando, Matt (ExonHit 200801 appointed Head of new Therapeutics Unit) |
n. a. |
Eurobio Scientific (Group) |
France |
Parikh, Tobias |
n. a. |
LSA Life Science Agency GmbH |
Germany |
Parkhill, Julian (Sanger Institute 200812 Director of Sequencing) |
n. a. |
Wellcome Trust, The |
United Kingdom (GB) |
Parrett, William G. (Deloite Touche –2007 retired) |
n. a. |
Deloitte Touche Tohmatsu (Group) |
United Kingdom (GB) |
Pascoe, Richard W. (Ariad 200702 VP + CCO) |
n. a. |
Takeda (Group) |
United States (USA) |
Passioukov, Alexandre (Pierre Fabre 201805 VP Translational Medicine at IRPF) |
n. a. |
Pierre Fabre (Group) |
France |
Patel, Parasvil (Radical Ventures 202211 Partner) |
n. a. |
|
|
Patterson, John (AstraZeneca 200608–200903 Exec Director Development) |
n. a. |
AstraZeneca (Group) |
United Kingdom (GB) |
Pauluzzi, David P. (Water Street Healthcare Partners 200802) |
n. a. |
Water Street Healthcare Partners LLC |
United States (USA) |
Pay, Nick (GenomicsVisions 2005– Principal before OTG + Cytomyx plc + Kalibrant Ltd + Roche Diagnostics) |
n. a. |
GenomicsVisions Consultants |
United Kingdom (GB) |
Peakman, Tim (UK Biobank 200601– Executive Director) |
n. a. |
UK Biobank Ltd. |
United Kingdom (GB) |
Pearce-Palmer, Rhys (Cardiff Medicentre 202205 Innovation Business Manager) |
n. a. |
Cardiff University |
United Kingdom (GB) |
Pederson, Ove (Curalogic 200610 VP Development) |
n. a. |
Curalogic A/S |
Denmark |
Peeters, Kris (EU (govt) 202112 VP at EIB) |
n. a. |
EU (govt) |
Luxembourg |
Peine, Günter (BioTop 200503) |
n. a. |
Berlin (govt region) |
Germany |
Pelkmans, Lucas (ETH Zurich 200603) |
n. a. |
ETH Zürich (ETHZ) |
Switzerland |
Pence, Mike |
n. a. |
United States (govt) |
United States (USA) |
Pendse, Girish (BMS 202109) |
n. a. |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
Peragovics, Ágnes (ChemAxon 201504) |
n. a. |
ChemAxon (Group) |
Hungary |
Pergande, Paul (Grant Instruments 200712 Head Grant Technologies) |
n. a. |
Grant Instruments (Group) |
United Kingdom (GB) |
Perry, Benjamin (DNDi 201909 Senior Discovery Manager + Research Scientist) |
n. a. |
DNDi (Drugs for Neglected Diseases initiative) |
Switzerland |
Persing, David H. (Cepheid 200508–) |
n. a. |
Danaher (Group) |
United States (USA) |
Peters, Sabine (Amodia Bioservice 2003) |
n. a. |
Amodia Bioservice GmbH |
Germany |
Peters, Sonja (Q-Bioanalytic 200607) |
n. a. |
Eurofins (Group) |
Germany |
Pfeiler, Andreas (Nycomed 200606 Senior VP Central and Southern Europe) |
n. a. |
General Electric (Group) |
Norway |
Pfleiderer, Wolfgang (Chemogenix 2000) |
n. a. |
Roche (Group) |
Germany |
Philippsen, Peter |
n. a. |
University of Basel |
Switzerland |
Philips, Craig W. (Cell Therapeutics 200808– before Bayer Healthcare Oncology) |
n. a. |
Cell Therapeutics (Group) |
United States (USA) |
Pickles, Janette (Univ London 201510 Operations Manager at London BioScience Innovation Centre) |
n. a. |
University of London |
United Kingdom (GB) |
Pieper, Dietmar (GBF 200503) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Pierce, Eric (BioCentury 201711 Publisher) |
n. a. |
BioCentury Publications Inc. |
United States (USA) |
Pirooznia, Nima (Kompass Prive Equity 200912) |
n. a. |
Kompass (Group) |
Germany |
Plate, Klaus (Technologiepark Heidelberg 200501) |
n. a. |
Heidelberg (govt city) |
Germany |
Platt, Mike (Netherton Investments 202201 Owner before BlueCrest Capital + JP Morgan) |
n. a. |
|
|
Plattner, Hasso (SAP founder) |
n. a. |
HassoPlattnerVentures Management GmbH |
Germany |
Plicka, Jan (Elisa Development 202302) |
n. a. |
Institute of Macromolecular Chemistry of the CAS v. v. i. (IMC, CZ) |
Czech Republic |
Plümpe, Jörg (Active Motif Chromeon GmbH 200901) |
n. a. |
Active Motif (Group) |
Germany |